Prescient Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.386x

Prescient Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, Prescient Therapeutics Ltd (PTX) has a cash flow conversion efficiency ratio of -0.386x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.54 Million ≈ $-4.63 Million USD) by net assets (AU$16.97 Million ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Prescient Therapeutics Ltd (1991–2025)

Cash flow conversion efficiency of Prescient Therapeutics Ltd from 1991 to 2025. This chart illustrates how Prescient Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Prescient Therapeutics Ltd stock quote for real-time trading data and today's change.

Prescient Therapeutics Ltd Cash Flow Conversion Ratio Explained

Prescient Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Prescient Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Prescient Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see market cap of Prescient Therapeutics Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jorjin Technologies TWO:4980	-0.015x
LORDS CHLORO ALKALI ORD T (BSE) NSE:LORDSCHLO	N/A
SSC Security Services Corp V:SECU	0.045x
Chilwa Minerals Ltd AU:CHW	-0.071x
Seafresh Industry Public Company Limited BK:CFRESH	0.070x
Feerum S.A. WAR:FEE	0.073x
Nido Education Ltd AU:NDO	0.049x
Cornerstone OnDemand Inc F:8CO	0.014x

Annual Cash Flow Conversion Efficiency for Prescient Therapeutics Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Prescient Therapeutics Ltd from 1991 to 2025. Review how much free cash does Prescient Therapeutics Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$11.39 Million ≈ $8.06 Million	AU$-7.24 Million ≈ $-5.13 Million	-0.636x	-55.35%
2024-06-30	AU$18.07 Million ≈ $12.78 Million	AU$-7.40 Million ≈ $-5.23 Million	-0.409x	-72.46%
2023-06-30	AU$26.08 Million ≈ $18.45 Million	AU$-6.19 Million ≈ $-4.38 Million	-0.237x	+7.72%
2022-06-30	AU$16.76 Million ≈ $11.86 Million	AU$-4.31 Million ≈ $-3.05 Million	-0.257x	-32.38%
2021-06-30	AU$20.43 Million ≈ $14.45 Million	AU$-3.97 Million ≈ $-2.81 Million	-0.194x	+6.16%
2020-06-30	AU$11.19 Million ≈ $7.92 Million	AU$-2.32 Million ≈ $-1.64 Million	-0.207x	+29.30%
2019-06-30	AU$14.32 Million ≈ $10.13 Million	AU$-4.20 Million ≈ $-2.97 Million	-0.293x	-28.67%
2018-06-30	AU$9.44 Million ≈ $6.68 Million	AU$-2.15 Million ≈ $-1.52 Million	-0.228x	+18.15%
2017-06-30	AU$11.78 Million ≈ $8.34 Million	AU$-3.28 Million ≈ $-2.32 Million	-0.278x	-132.19%
2016-06-30	AU$13.01 Million ≈ $9.21 Million	AU$-1.56 Million ≈ $-1.10 Million	-0.120x	+76.20%
2015-06-30	AU$4.45 Million ≈ $3.15 Million	AU$-2.24 Million ≈ $-1.59 Million	-0.503x	-124.50%
2014-06-30	AU$5.03 Million ≈ $3.56 Million	AU$-1.13 Million ≈ $-797.64K	-0.224x	-137.84%
2012-06-30	AU$-1.79 Million ≈ $-1.26 Million	AU$-1.06 Million ≈ $-749.33K	0.593x	-38.23%
2011-06-30	AU$-832.03K ≈ $-588.72K	AU$-798.32K ≈ $-564.86K	0.959x	+128.20%
2010-06-30	AU$278.83K ≈ $197.29K	AU$-948.56K ≈ $-671.16K	-3.402x	-273.69%
2009-06-30	AU$-604.48K ≈ $-427.71K	AU$-1.18 Million ≈ $-837.69K	1.959x	+111.72%
2008-06-30	AU$73.05K ≈ $51.69K	AU$-1.22 Million ≈ $-863.74K	-16.710x	-590.36%
2007-06-30	AU$1.77 Million ≈ $1.25 Million	AU$-4.28 Million ≈ $-3.03 Million	-2.421x	-15.33%
2006-06-30	AU$2.03 Million ≈ $1.43 Million	AU$-4.25 Million ≈ $-3.01 Million	-2.099x	-111.44%
2005-06-30	AU$2.83 Million ≈ $2.00 Million	AU$-2.81 Million ≈ $-1.99 Million	-0.993x	+4.43%
2004-06-30	AU$3.64 Million ≈ $2.57 Million	AU$-3.78 Million ≈ $-2.67 Million	-1.039x	+69.18%
2003-06-30	AU$953.60K ≈ $674.73K	AU$-3.21 Million ≈ $-2.27 Million	-3.369x	-105.38%
2002-06-30	AU$1.46 Million ≈ $1.03 Million	AU$-2.39 Million ≈ $-1.69 Million	-1.641x	-165.89%
2001-06-30	AU$3.61 Million ≈ $2.56 Million	AU$-2.23 Million ≈ $-1.58 Million	-0.617x	+64.76%
2000-06-30	AU$1.28 Million ≈ $903.24K	AU$-2.23 Million ≈ $-1.58 Million	-1.751x	-281.36%
1999-06-30	AU$2.68 Million ≈ $1.89 Million	AU$-1.23 Million ≈ $-869.86K	-0.459x	+58.73%
1998-06-30	AU$1.17 Million ≈ $830.02K	AU$-1.30 Million ≈ $-923.14K	-1.112x	+96.97%
1997-06-30	AU$24.34K ≈ $17.22K	AU$-893.39K ≈ $-632.13K	-36.710x	-311.58%
1996-06-30	AU$-41.55K ≈ $-29.40K	AU$-720.86K ≈ $-510.06K	17.351x	+23.87%
1995-06-30	AU$-134.00K ≈ $-94.81K	AU$-1.88 Million ≈ $-1.33 Million	14.007x	+810.95%
1994-06-30	AU$336.00K ≈ $237.74K	AU$-662.00K ≈ $-468.41K	-1.970x	-161.86%
1993-06-30	AU$546.00K ≈ $386.33K	AU$1.74 Million ≈ $1.23 Million	3.185x	+623.82%
1991-06-30	AU$1.66 Million ≈ $1.17 Million	AU$730.00K ≈ $516.52K	0.440x	--

About Prescient Therapeutics Ltd

AU:PTX Australia Biotechnology

Market Cap

$40.18 Million

AU$56.78 Million AUD

Market Cap Rank

#22455 Global

#795 in Australia

Share Price

AU$0.05

Change (1 day)

+1.89%

52-Week Range

AU$0.05 - AU$0.11

All Time High

AU$0.30